Post-IPO Equity Life Science Companies

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Xlife Sciences focuses on the performance and growth of life science technologies.

Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

Psyence Biomedical is a life science biotechnology company that focuses on advancement of psychedelic medicines.

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

FendX Technologies is a technology company developing surface protection products that protect surfaces from pathogen contamination.

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products.

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.